Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q46826215)
Watch
English
Darbepoetin alfa is more potent in vivo and can be administered less frequently than rHuEPO.
scientific article published in August 2002
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
2376125
retrieved
25 December 2017
reference URL
http://europepmc.org/abstract/PMC/2376125
title
Darbepoetin alfa is more potent and can be administered less frequently than rHuEPO
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
2376125
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2376125&resulttype=core&format=json
retrieved
9 May 2020
main subject
darbepoetin alfa
0 references
author name string
J Egrie
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
2376125
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2376125&resulttype=core&format=json
retrieved
9 May 2020
J Browne
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
2376125
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2376125&resulttype=core&format=json
retrieved
9 May 2020
language of work or name
English
0 references
publication date
1 August 2002
1 reference
stated in
Europe PubMed Central
PMC publication ID
2376125
retrieved
25 December 2017
reference URL
http://europepmc.org/abstract/PMC/2376125
published in
British Journal of Cancer
1 reference
stated in
Europe PubMed Central
PMC publication ID
2376125
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2376125&resulttype=core&format=json
retrieved
9 May 2020
volume
87
1 reference
stated in
Europe PubMed Central
PMC publication ID
2376125
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2376125&resulttype=core&format=json
retrieved
9 May 2020
issue
4
1 reference
stated in
Europe PubMed Central
PMC publication ID
2376125
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2376125&resulttype=core&format=json
retrieved
9 May 2020
page(s)
476-477
1 reference
stated in
Europe PubMed Central
PMC publication ID
2376125
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2376125&resulttype=core&format=json
retrieved
9 May 2020
cites work
Development and characterization of novel erythropoiesis stimulating protein (NESP)
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376125
retrieved
24 May 2018
Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376125
retrieved
15 August 2018
Identifiers
DOI
10.1038/SJ.BJC.6600506
1 reference
stated in
Europe PubMed Central
PMC publication ID
2376125
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2376125&resulttype=core&format=json
retrieved
9 May 2020
PMC publication ID
2376125
1 reference
stated in
Europe PubMed Central
PMC publication ID
2376125
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2376125&resulttype=core&format=json
retrieved
9 May 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
